Search Results - "PHILIP, Irène"
-
1
Does adoption of electronic health records improve the quality of care management in France? Results from the French e-SI (PREPS-SIPS) study
Published in International journal of medical informatics (Shannon, Ireland) (01-06-2017)“…Highlights • This study provides empirical proof of EHR benefits on the quality of care management. • Hospitals that adopted EHRs have better results for…”
Get full text
Journal Article -
2
l‐asparaginase loaded red blood cells in refractory or relapsing acute lymphoblastic leukaemia in children and adults: results of the GRASPALL 2005‐01 randomized trial
Published in British journal of haematology (01-04-2011)“…Summary l‐asparaginase encapsulated within erythrocytes (GRASPA®) should allow serum asparagine depletion over a longer period than the native form of the…”
Get full text
Journal Article -
3
Does adoption of electronic health records improve organizational performances of hospital surgical units? Results from the French e-SI (PREPS-SIPS) study
Published in International journal of medical informatics (Shannon, Ireland) (01-02-2017)“…Highlights • This study provides empirical proof of EHR benefits on organizational performances. • Hospitals that adopted EHRs have better material resource…”
Get full text
Journal Article -
4
Immunologic and Clinical Effects of Injecting Mature Peptide-Loaded Dendritic Cells by Intralymphatic and Intranodal Routes in Metastatic Melanoma Patients
Published in Clinical cancer research (15-12-2006)“…Purpose: A phase I/II trial was conducted to evaluate clinical and immunologic responses after intralymphatic and intranodal injections of mature dendritic…”
Get full text
Journal Article -
5
-
6
Influenza Vaccination in Patients with Hematologic Malignancies: Analysis of Practices in 200 Patients in a Single Center
Published in Blood (16-11-2008)“…Vaccination against influenza in patients with hematologic malignancies has long been a matter of clinical uncertainty. Recent studies demonstrated the…”
Get full text
Journal Article -
7
GRASPALL 2005.01 Clinical Study: L-Asparaginase Loaded into Red Blood Cells Is Effective at Depleting Serum Asparagine in Children and Adults with Relapsed Acute Lymphoblastic Leukaemia (ALL)
Published in Blood (16-11-2008)“…L-asparaginase has been a mainstay of ALL treatment since decades and its efficacy has been demonstrated in a broad range of patient's profiles. However its…”
Get full text
Journal Article -
8
Lymphopenia Prior High-Dose Chemotherapy Is a Major Prognostic Factor for Severe Infectious Complication after Autologous Blood Stem Cell Transplantation for Lymphoma's Patients
Published in Blood (16-11-2006)“…Rationale: Host factors able to predict accurately the infectious risk after high dose chemotherapy (HDCT) and autologous stem cell transplantation (ASCT)…”
Get full text
Journal Article -
9
Comparison of Outcome of Unselected Patients with Diffuse Large B-Cell Lymphoma Diagnosed before and after Approval of Rituximab in France in This Indication
Published in Blood (16-11-2005)“…Two randomized-controlled trials had demonstrated improved outcome with adding rituximab to CHOP for elderly patients and young low-risk patients with DLBCL…”
Get full text
Journal Article -
10
Combination of rituximab with chemotherapy in diffuse large B-cell lymphoma. Evaluation in daily practice before and after approval of rituximab in this indication
Published in Hematological oncology (01-09-2008)“…Randomized trials have demonstrated improved outcome from adding rituximab to CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) for patients with…”
Get full text
Journal Article -
11
Analysing the attributes of Comprehensive Cancer Centres and Cancer Centres across Europe to identify key hallmarks
Published in Molecular oncology (01-05-2021)“…There is a persistent variation in cancer outcomes among and within European countries suggesting (among other causes) inequalities in access to or delivery of…”
Get full text
Journal Article -
12
Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma
Published in Cancer Immunology, Immunotherapy (01-11-2008)“…Purpose γ9δ2 T lymphocytes have been shown to be directly cytotoxic against renal carcinoma cells. Lymphocytes T γδ can be selectively expanded in vivo with…”
Get full text
Journal Article -
13
-
14
Peripheral blood stem cell and bone marrow transplantation for solid tumors and lymphomas : Hematologic recovery and costs : A randomized, controlled trial
Published in Annals of internal medicine (15-04-1997)“…Previous studies have suggested that peripheral blood stem cell (PBSC) transplantation has an advantage over autologous bone marrow transplantation. To compare…”
Get full text
Journal Article -
15
Phase-I study of Innacell [gamma][Delta](TM), an autologous cell-therapy product highly enriched in [gamma]9[Delta]2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma
Published in Cancer immunology, immunotherapy (01-11-2008)“…[gamma]9[Delta]2 T lymphocytes have been shown to be directly cytotoxic against renal carcinoma cells. Lymphocytes T [gamma][Delta] can be selectively expanded…”
Get full text
Journal Article -
16
Phase-I study of Innacell gammadelta, an autologous cell-therapy product highly enriched in gamma9delta2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma
Published in Cancer immunology, immunotherapy : CII (01-11-2008)“…gamma9delta2 T lymphocytes have been shown to be directly cytotoxic against renal carcinoma cells. Lymphocytes T gammadelta can be selectively expanded in vivo…”
Get full text
Journal Article -
17
Transplantation with selected autologous peripheral blood CD34 +Thy1 + hematopoietic stem cells (HSCs) in multiple myeloma : Impact of HSC dose on engraftment, safety, and immune reconstitution
Published in Experimental hematology (01-07-2000)“…The aims of our study performed in myeloma were to evaluate the performance and the safety of Systemix's high-speed clinical cell sorter, to assess the safety…”
Get full text
Journal Article -
18
-
19
-
20
CD4 lymphopenia to identify end-of-life metastatic cancer patients
Published in European journal of cancer (1990) (01-03-2013)“…Abstract Background Cancer patients with CD4 lymphopenia have an increased risk of severe toxicity after administration of cytotoxic chemotherapy. The impact…”
Get full text
Journal Article